Skip to main content

Table 1 Patient characteristics

From: Comparison of nalbuphine versus magnesium sulfate as an adjuvant to intrathecal hyperbaric bupivacaine (0.5%) in infraumbilical surgeries

Patient characteristics

 

Group A

Group B

Group C

P value

Inference

Age (years)

34.63 ± 11.45

33.87 ± 11.03

36.76 ± 10.77

A-B = 0.794

B-C = 0.308

C-A = 0.461

NS

Height (cm)

167.53 ± 5.77

167.53 ± 7.90

165 ± 6.94

A-B = 1.000

B-C = 0.192

C-A = 0.130

NS

Weight (kg)

54.1 ± 6.31

55.5 ± 5.83

56.13 ± 6.99

A-B = 0.375

B-C = 0.706

C-A = 0.242

NS

Sex (M/F)

17/13

18/12

16/14

> 0.05

NS

ASA I/II

20 (66.66%)

10 (33.33%)

19 (63.33%)

11 (36.66%)

18 (60%)

12 (40%)

> 0.05

NS

Duration of surgery (min)

133 ± 22.15

132.33 ± 24.45

128.33 ± 26.4

A-B = 0.911

B-C = 0.513

C-A = 0.460

NS

  1. Demographically all groups are comparable. There were no significant differences among them
  2. OAA score and vitals monitoring: OAA score and SpO2, HR, SBP, DBP, and respiratory rate were monitored periodically in each patient in each group perioperative period. There was no statistically significant difference present among the three groups at any time during the study (P> 0.05)